Swiss Auto Components Stock News

SWX:BEAN
SWX:BEANBuilding

Is BELIMO Holding (SWX:BEAN) Fully Valued After Its Half Year Results And Guidance?

BELIMO Holding (SWX:BEAN) drew fresh attention after reporting half year 2026 results, with sales of CHF 676.4 million and net income of CHF 124.9 million, while reiterating guidance for an EBIT margin above 20% for the full year. See our latest analysis for BELIMO Holding. The CHF 842.0 share price has risen over the past week, with a 7 day share price return of 4.99% and a 90 day share price return of 16.78%, although the 1 year total shareholder return is down 6.47% while the 3 year total...
SWX:CLN
SWX:CLNChemicals

Clariant (SWX:CLN) Faces A Fresh Legal Test Following Dow Europe Claim And Fair Value Debate

Clariant (SWX:CLN) has drawn investor attention after Dow Europe filed a new legal claim in the Dortmund court, seeking about €1,100 million in damages related to alleged past competition law infringements. See our latest analysis for Clariant. Since the announcement, Clariant’s share price has been volatile, with a 1-day share price return of 2.13% but a 7-day share price return that declined 3.57%, while the 1-year total shareholder return is down 11.52%. This points to fading longer term...
SWX:SGSN
SWX:SGSNProfessional Services

SGS (SWX:SGSN) Stock Faces Softer H1 EPS Challenging Margin Expansion Narrative

SGS (SWX:SGSN) has posted its H1 2026 results with revenue of CHF3.7b and basic EPS of CHF1.58, while trailing twelve month revenue stands at CHF7.2b with EPS of CHF3.42 alongside year over year earnings growth of 5.6%. Over recent periods the company has seen revenue move from CHF3.4b in H1 2025 to CHF3.5b in H2 2025 and then to CHF3.7b in H1 2026, with half year EPS shifting from CHF1.64 to CHF1.83 and then to CHF1.58, setting up a picture of steady scale and modestly improving net profit...
SWX:VONN
SWX:VONNCapital Markets

Vontobel Holding (SWX:VONN) Stock Tested As Net Profit Margin Jumps To 23.9% And Upside Debated

Vontobel Holding (SWX:VONN) has just posted its H1 2026 scorecard, with investors eyeing the trailing 12-month revenue of CHF1.59b and basic EPS of CHF6.77 as the key markers of current momentum. Over the recent reporting periods, total revenue has moved from CHF694.3m in H2 2024 to CHF741.7m in H2 2025, while basic EPS over those halves shifted from CHF2.44 to CHF2.94. This gives investors a clear read on how the top line and per share earnings are tracking into the latest numbers. With net...
SWX:OFN
SWX:OFNCommercial Services

Orell Füssli (SWX:OFN) Stock Faces Margin Decline That Tests Bullish Growth Narrative

Orell Füssli (SWX:OFN) has opened H1 2026 reporting season with neutral top line and earnings figures on a trailing basis, with TTM revenue at CHF 274.2 million and TTM basic EPS at CHF 8.35. This comes against a backdrop of forecast earnings growth of about 11.9% per year and revenue growth of about 4.8% per year. Over recent periods the company has seen half-year revenue move from CHF 145.41 million with basic EPS of CHF 6.40 in H2 2024, to CHF 120.10 million with EPS of CHF 3.41 in H1...
SWX:STGN
SWX:STGNMachinery

StarragTornos Group (SWX:STGN) Stock Faces Profit Forecast Decline After Return To EPS Of 2.50

StarragTornos Group (SWX:STGN) has reported its H1 2026 numbers with total revenue of CHF 444.4 million on a trailing twelve month basis and basic EPS of CHF 2.50, while the latest half year in 2025 showed revenue of CHF 223.9 million and basic EPS of CHF 2.64. The company has seen revenue move between CHF 239.1 million in H2 2024 and CHF 223.9 million in H2 2025, with basic EPS shifting from CHF 0.97 to CHF 2.64 over the same halves. This sets up a mixed but improving earnings picture. For...
SWX:CALN
SWX:CALNLuxury

Calida Holding (SWX:CALN) Stock Faces 1329% Earnings Swing That Tests Long‑Term Bearish Narratives

CALIDA Holding (SWX:CALN) has reported a cleaner set of numbers for H1 2026, with the latest trailing 12-month figures showing Total Revenue of CHF203.212 million and Basic EPS of CHF0.803, against a backdrop of very large earnings growth from a low base over the past year. Over recent periods, revenue has moved from CHF222.208 million in H1 2025 to CHF215.894 million in H2 2025 and CHF203.212 million on a trailing 12-month basis, while EPS has shifted from a loss of CHF0.074 per share in H1...
SWX:SWTQ
SWX:SWTQBuilding

Schweiter Technologies (SWX:SWTQ) Stock Faces EPS Loss As Profitability Concerns Challenge Bullish Narratives

Schweiter Technologies (SWX:SWTQ) has opened H1 2026 with revenue of CHF 410.7 million and a basic EPS loss of CHF 15.67, putting fresh numbers on a business that is still working through pressured profitability. The company has seen revenue move from CHF 483.5 million in H2 2024 to CHF 493.7 million in H1 2025 and then to CHF 410.7 million in H2 2025, with EPS swinging between a CHF 5.04 loss, CHF 9.10 profit, and a CHF 15.67 loss across those same periods. For investors, the latest release...
SWX:ALSN
SWX:ALSNElectronic

ALSO Holding (SWX:ALSN) Reports Stronger Half Year Results, Is The Stock Still Below Fair Value?

ALSO Holding (SWX:ALSN) is back in focus after its H1 2026 earnings call, where the company reported half year sales of €7,090.29 million and net income of €69.07 million. See our latest analysis for ALSO Holding. Despite the H1 2026 results drawing fresh attention, ALSO Holding’s 190.0 CHF share price reflects mixed momentum, with a recent 3.15% 1 day gain sitting alongside a year to date share price decline of 11.83% and a 1 year total shareholder return decline of 26.27%, even though the 3...
SWX:LONN
SWX:LONNLife Sciences

Can Lonza Group (SWX:LONN) Justify Its Valuation On Raised Margin Guidance?

Lonza Group (SWX:LONN) has attracted fresh attention after reporting first half 2026 results alongside new guidance, combining higher sales and earnings with an increased core EBITDA margin outlook and portfolio reshaping moves. See our latest analysis for Lonza Group. Over the past year Lonza Group’s share price return has been mixed, with a 14.21% 90 day gain and a 3.71% 30 day rise contrasting with a 2.34% decline in 1 year total shareholder return. This points to improving short term...
SWX:AVOL
SWX:AVOLSpecialty Retail

Avolta (SWX:AVOL) Could Be 31% Undervalued On Aruba Airport Extension

Avolta (SWX:AVOL) stock is in focus after the company secured an eight-year extension to run duty-free stores in Aruba Airport’s redeveloped terminals under the Gateway 2030 program. See our latest analysis for Avolta. The Aruba Airport extension follows a mixed year for Avolta’s stock, with the 1 month share price return down 13.73%, while the 1 year total shareholder return is 11.59% and the 3 year total shareholder return is 13.37%, suggesting gradually building momentum. If this kind of...
SWX:NESN
SWX:NESNFood

Nestlé (SWX:NESN) Stock Faces Margin Squeeze As Net Profitability Undercuts Bullish Growth Narrative

Nestlé (SWX:NESN) has opened H1 2026 with revenue of CHF43.3 billion and basic EPS of CHF1.35, while trailing twelve month revenue sits at CHF88.8 billion with EPS of CHF2.89, giving investors a detailed look at how the business is currently earning its money. Over the last three reported half year periods, revenue has moved from CHF44.4 billion in H1 2025 to CHF45.5 billion in H2 2025 and then CHF43.3 billion in H1 2026, while basic EPS shifted from CHF1.97 to CHF1.54 and then CHF1.35,...
SWX:KNIN
SWX:KNINShipping

Kuehne + Nagel International (SWX:KNIN) Stock Faces Margin Squeeze Despite Q2 EPS Improvement

Kuehne + Nagel International (SWX:KNIN) has reported fresh numbers for Q2 2026, with revenue of CHF 6.6b and basic EPS of CHF 2.26, alongside net income of CHF 268m. The company’s quarterly revenue has moved from CHF 6.1b and EPS of CHF 2.02 in Q2 2025 to CHF 6.6b and EPS of CHF 2.26 in the latest quarter. Trailing 12 month EPS stands at CHF 7.27 on revenue of CHF 24.2b. This sets the backdrop for how investors may interpret today’s figures in light of recent years of weaker earnings and...
SWX:MEDX
SWX:MEDXMedical Equipment

Medmix (SWX:MEDX) Stock Faces Tiny Profit After One Off Loss Tests Bullish Narratives

medmix (SWX:MEDX) has reported H1 2026 results with trailing 12 month revenue of CHF437 million and net income of CHF0.1 million, translating to EPS of CHF0.002. The latest reported half year for 2025 showed revenue of CHF222.6 million and a net loss of CHF0.4 million, or EPS of CHF0.0096. Over the last few reported periods, revenue has moved from CHF242.7 million in H2 2024 to CHF225.4 million in H1 2025 and CHF222.6 million in H2 2025. Over the same timeframe, EPS shifted from a loss of...
SWX:LEON
SWX:LEONCapital Markets

Leonteq (SWX:LEON) Stock Faces Widening Losses Challenging Bullish Earnings Recovery Narrative

Leonteq (SWX:LEON) has kicked off H1 2026 earnings season with a mixed picture, as trailing 12 month figures show total revenue of CHF157.7 million alongside a loss of CHF30.3 million in net income and a basic EPS loss of CHF1.70, while the most recent reported half year in 2025 showed H2 revenue of CHF46.7 million with a net income loss of CHF43.0 million and basic EPS loss of CHF2.42. Over recent halves, total revenue has ranged from CHF104.3 million in H2 2024 to CHF123.7 million in H1...
SWX:ROP
SWX:ROPPharmaceuticals

Roche (SWX:ROG) Stock Margin Expansion To 19.6% Tests Bullish Earnings Narratives

Roche Holding (SWX:ROG) has reported its H1 2026 results with trailing twelve month revenue of CHF 62.96 billion and net income of CHF 12.34 billion, while the latest half year period shows revenue of CHF 31.51 billion, net income of CHF 5.47 billion and basic EPS of CHF 6.87. Over recent half year periods, the company has seen revenue move from CHF 31.64 billion in H2 2024 to CHF 31.85 billion in H1 2025 and CHF 31.51 billion in H2 2025, alongside basic EPS shifting from CHF 2.53 to CHF 9.31...
SWX:CMBN
SWX:CMBNConsumer Finance

Cembra Money Bank (SWX:CMBN) Stock EPS Stability Reinforces Profitability‑Focused Narratives

Cembra Money Bank (SWX:CMBN) has reported H1 2026 total revenue of CHF 231.0 million and net income of CHF 92.3 million, with basic EPS at CHF 3.15, setting a clear marker for the latest half year. The company has seen half year revenue move from CHF 235.9 million in H1 2025 to CHF 232.7 million in H2 2025 and then to CHF 231.0 million in H1 2026. Over that same H1-to-H1 period, basic EPS shifted from CHF 2.97 to CHF 3.15, giving investors a straightforward picture of how top line and EPS...
SWX:VACN
SWX:VACNMachinery

VAT Group (SWX:VACN) Reports 102% Order Intake Growth, Is The Upside Already Priced In?

Why VAT Group Stock Is Back in Focus After New Guidance VAT Group (SWX:VACN) is back on investors’ radar after reporting 102% year over year growth in order intake, confirming higher full year 2026 sales and net income guidance, and outlining ongoing capacity expansion. See our latest analysis for VAT Group. At a share price of CHF650.6, VAT Group has given investors a 50.39% year to date share price return and a very large 1 year total shareholder return of 127.72%. Shorter term momentum has...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo (SWX:COPN) Stock Faces Trailing Loss That Tests Bullish Growth Narrative

Cosmo (SWX:COPN) has reported its H1 2026 results with trailing 12 month revenue of €102.7 million and a loss of €6.4 million, translating to an EPS loss of €0.38, while the current share price sits at CHF63.6. The company has seen revenue move from €130.6 million in H2 2024 to €52.5 million in H2 2025 on a half year basis, with EPS shifting from €3.73 to a loss of €0.10 over the same periods. This sets up a results season in which investors are weighing forecasted growth against pressure on...